Newer antiepileptic drugs: rash, mood, kidney stones and safe stopping

Know the one signature risk for each drug

These three medicines are often grouped as newer antiepileptics, yet the exam rarely tests them as interchangeable. Lamotrigine is linked to serious skin reactions, levetiracetam to behavioural and mood change, and topiramate to kidney stones, reduced sweating and metabolic acidosis. Anchoring each drug to its signature risk helps you choose the assessment that matters most in a question.

All three share a class-wide concern: antiepileptic drugs carry a warning about suicidal thoughts and behaviour, and changes can appear soon after starting. Ask about mood, sleep, agitation and self-harm thoughts at every contact, and teach families to report sudden behavioural change. This is part of routine monitoring, not a reason to withhold prescribed seizure treatment without discussion.

Treat any new rash on lamotrigine as a reportable event

Serious lamotrigine rashes, including Stevens-Johnson syndrome, usually appear during the first two to eight weeks, although they can occur later. Children and adolescents are at higher risk than adults. Risk also rises when lamotrigine is combined with valproate, or when the starting dose is too high or increased faster than the prescribed schedule.

Because the nurse cannot reliably tell a benign rash from an early severe reaction at the bedside, any new rash should be reported promptly, especially with fever, blistering, mouth sores or peeling skin. Holding the next dose pending prescriber review is a reasonable exam answer. Check that the titration schedule is clear and that the patient understands why doses go up slowly.

Watch mood with levetiracetam and fluids with topiramate

Levetiracetam can make people feel agitated, irritable or aggressive, and it may be unsuitable for someone with current thoughts of self-harm. Families often notice these changes first, so ask them directly. Levetiracetam can also rarely affect the kidneys; report markedly reduced urine output, new swelling of the legs or unexplained confusion.

Topiramate raises the risk of kidney stones, so teach steady daily fluid intake and report flank pain or blood in the urine. It can reduce sweating, which matters for children playing outdoors in hot weather; report fever, muscle cramps or overheating. Sudden blurred vision or eye pain needs urgent review, and topiramate can reduce the effectiveness of hormonal contraception.

Ask about sleep, appetite and school or work performance at follow-up visits as well. Dizziness and drowsiness are common early with all three medicines, so advise avoiding driving, cycling in traffic or swimming alone until the person knows how the medicine affects them and local rules on driving after seizures are followed.

Teach safe stopping, contraception and missed-dose planning

Abruptly stopping any antiepileptic drug can provoke seizures, including prolonged seizures, even in someone whose control has been good. If a medicine needs to be withdrawn, the prescriber plans a gradual reduction. Teach patients to keep a supply on hand, refill early and contact the prescriber rather than stopping because of side effects.

Discuss contraception and pregnancy plans with people who could become pregnant. Hormonal contraceptives can interact with lamotrigine, and topiramate can make hormonal methods less reliable while carrying significant pregnancy risks. Teach patients to tell every prescriber and pharmacist about their seizure medicine so interactions are checked before any new drug is started.

Work a hypothetical rash question

Imagine a hypothetical 14-year-old who started lamotrigine three weeks ago and now has a red rash on the trunk with a low-grade fever. Options include applying an emollient and reassessing tomorrow, giving the next dose because seizures are well controlled, or holding the dose and notifying the prescriber. The last option is strongest because the timing, age and fever all raise concern for a serious reaction.

Applying cream treats the rash as minor without investigating it. Giving the next dose continues exposure to a possible trigger. In real practice the prescriber decides whether lamotrigine is stopped and how seizure protection is maintained, so escalation should include the seizure history and current medicines, especially any valproate.

Sources and further reading

MedlinePlus: Lamotrigine. Boxed rash warning, timing in the first weeks, higher risk in children, valproate interaction, slow titration, suicidal thoughts and avoiding abrupt stopping.

MedlinePlus: Topiramate. Kidney stones and fluids, eye symptoms, decreased sweating, metabolic acidosis, mood change, abrupt-stop seizures and contraceptive interaction.

NHS: Levetiracetam. Agitation, irritability and aggression, caution with self-harm thoughts, gradual withdrawal and uncommon kidney problems.

NHS: Topiramate. Metabolic acidosis, reduced hormonal contraceptive effect and the need for contraception because of serious pregnancy risks.